• contact@literaturepublishers.org
  • Whitley Bay NE26 2HU, England, United Kingdom
  • Open Access
Article Details
Clinical Image
Volume 4, Issue 10 (October Issue)

Dyspnea in a Young Patient Undergoing In vitro Fertilization Treatment

Miriam Manzanares Garcia-Faria1*, Iñaki Marina Clopes2 and Magdalena Muelas Fernandez2

1Family physician, Costa Ponent Teaching Unit, Metropolitan South, Institut Català de la Salut, Viladecans (Barcelona), Spain

2Internal Medicine Department, Hospital of Viladecans, Institut Català de la Salut, Viladecans (Barcelona), Spain

*Corresponding author: Miriam Manzanares Garcia-Faria, Family physician, Costa Ponent Teaching Unit, Metropolitan South, Institut Català de la Salut, Viladecans (Barcelona), Spain. E-mail: miriamgf82@gmail.com

Received: September 12, 2022; Accepted: September 19, 2022; Published: October 04, 2022

Citation: Manzanares - Garcia-Faria M, Marina - Clopes I, Muelas - Fernandez M. Dyspnea in a Young Patient Undergoing In vitro Fertilization Treatment. Clin Image Case Rep J. 2022; 4(10): 266.

Abstract

A 32-year-old woman was admitted to our internal medicine ward for dyspnea and pain in right hemithorax. Patient was on folic acid 5 mg/day and progesterone 600 mg/day due to invitro-fertilization treatment. Physical examination revealed heart rate was 110 bpm, Oxygen saturation was 93% and right basal hypophonesis on her chest was noted. The dyspnea-onset started 5 days before eventually progressing at rest. Laboratory findings indicated increased hematocrit and leukocytosis with evidence of hypersegmented neutrophils (Hematocrit 48%, WBC 19.5 x 109/L-Neutrophils 84.5%). X-rays revealed moderate pleural effusion in right hemithorax and CT-scan showed no signs of pulmonary embolism but confirmed bilateral pleural effusion with a right predominance and free peri-splenic fluid. In addition, a transvaginal-US was performed (Figure 1).

Keywords: Ovarian hyperstimulation syndrome; Assisted reproductive technology